MIC + L-Carnitine + B12 vs Tirzepatide
A side-by-side research comparison of MIC + L-Carnitine + B12 and Tirzepatide across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | MIC + L-Carnitine + B12 | Tirzepatide |
|---|---|---|
| Full name | Lipotropic Injection Blend (Methionine, Inositol, Choline + L-Carnitine + B12) | Tirzepatide (Dual GIP/GLP-1 Receptor Agonist) |
| Category | Weight Management | Weight Management |
| Status | Compounded medication | FDA Approved |
| Mechanism | Methionine aids fat breakdown and detoxification. Inositol helps redistribute body fat and improves insulin signaling. Choline prevents fat deposits in the liver. L-Carnitine shuttles fatty acids into mitochondria for oxidation. B12 supports energy metabolism and red blood cell formation. | Activates both GIP and GLP-1 receptors simultaneously for synergistic effects on insulin secretion, appetite reduction, and fat metabolism. GIP activation enhances fat oxidation and energy expenditure. |
| Molecular weight | Blend (multiple active compounds) | 4,814 Da |
| Half-life | Variable by component; B12 ~6 days, L-Carnitine ~17 hours | 5 days (120 hours) |
| Bioavailability | ~100% (intramuscular injection) | High (SubQ ~80%) |
| Typical dose | 1 mL injection (standardized blend) | 2.5 mg → titrate up to 15 mg |
| Frequency | 1-2x weekly | Once weekly |
| Route | Intramuscular injection | Subcutaneous injection |
MIC + L-Carnitine + B12 reported benefits
- Enhanced fat metabolism
- Increased energy levels
- Liver support and detoxification
- Improved mood and mental clarity
- Support for B12 deficiency
Tirzepatide reported benefits
- Superior weight loss (20-25%)
- Excellent glycemic control
- Reduced triglycerides
- Lower blood pressure
- Improved insulin sensitivity
- Potential MASH benefits
Related comparisons
Research and educational reference only. Not medical advice.